Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
No safety signals related to the vaccine candidate were identified
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
Subscribe To Our Newsletter & Stay Updated
